• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [16929 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Rapid Collaborative Review on the role of antibody tests for novel coronavirus SARS-CoV-2 in the management of the current pandemic
2020     NIHR Health Technology Assessment programme Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Interventions to reduce the risk of surgically transmitted Creutzfeldt–Jakob disease: a cost-effective modelling review
2020     Swiss Federal Office of Public Health (FOPH) Chondroitin Sulfate in Osteoarthritis
2020     NIHR Health Technology Assessment programme Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis
2020     Austrian Institute for Health Technology Assessment (AIHTA) Update 12 months follow-up: Nusinersen in spinal muscular atrophy ("late onset") in children and adolescents ≥ 6 years
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Leadless pacemaker for right ventricle pacing (Update 2020)
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Extracorporeal cytokine haemadsorption therapy in patients with sepsis or SIRS. Update 2020
2020     Ontario Health Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure
2020     Ontario Health Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Intrauterine ultrasound-guided transcervical radiofrequency ablation
2020     Center for Drug Evaluation (CDE) The health technology assessment of bipolar TURP, bipolar TUVP (vaporization of the prostate), Green Light TM, thulium, holmium, and diode laser prostatectomy in Taiwan
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Percutaneous Transvascular Implantation of a Coronary Sinus Reducing Stent
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Radiofrequency-Induced Intravesical Chemohyperthermia for Non-Muscle-Invasive Bladder Cancer
2020     Ontario Health Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vascular-targeted photodynamic therapy with padeliporfin (Tookad® Soluble)
2020     Ontario Health Cell-Free Circulating Tumour DNA Blood Testing to Detect EGFR T790M Mutation in People With Advanced Non–Small Cell Lung Cancer: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Health Services Research in Oncology. Part I: End-of-Life Care
2020     Austrian Institute for Health Technology Assessment (AIHTA) Covid-19: HSS/ Horizon Scanning Living Document (v01 April 2020) Part 1; Covid-19: HSS/ Horizon Scanning Living Document (v01 April 2020) Part 2 (Appendix)
2020     Ontario Health 10-kHz high-frequency spinal cord stimulation for adults with chronic noncancer pain: a health technology assessment
2020     Ontario Health Continual Long-Term Physiotherapy After Stroke: A Health Technology Assessment
2020     Ontario Health Extracorporeal Membrane Oxygenation for Cardiac Indications in Adults: A Health Technology Assessment
2020     Ontario Health 5-Aminolevulinic Acid Hydrochloride (5 ALA)–Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment
2020     Ontario Health Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment
2020     Ontario Health Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment
2020     Health Technology Wales (HTW) The clinical effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Treatment of benign thyroid by thermal laser or radiofrequency ablation]
2020     NIHR Health Technology Assessment programme Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review
2020     NIHR Health Services and Delivery Research programme Medication management in older people: the MEMORABLE realist synthesis
2020     NIHR Health Technology Assessment programme Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
2020     NIHR Health Services and Delivery Research programme Access to primary and community health-care services for people 16 years and over with intellectual disabilities: a mapping and targeted systematic review
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
2019     NIHR Health Technology Assessment programme Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019     NIHR Health Technology Assessment programme Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation
2019     NIHR Health Technology Assessment programme Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation
2019     NIHR Health Technology Assessment programme Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2019     NIHR Horizon Scanning Centre (NIHR HSC) An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study
2019     NIHR Health Technology Assessment programme Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation
2019     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Stereotactic neurosurgery frameless. The iSYS1® Robotic device]
2019     Andalusian Health Technology Assessment Area (AETSA) PET usefulness in non-oncological indications
2019     Andalusian Health Technology Assessment Area (AETSA) Clinical Utility of Procalcitonin–Guidance for initiation of antimicrobian treatment in patients admitted to the ICU
2019     NIHR Public Health Research (PHR) programme Mass media to communicate public health messages in six health topic areas: a systematic review and other reviews of the evidence
2019     Adelaide Health Technology Assessment (AHTA) Alpha Thalassaemia genetic testing
2019     Swiss Federal Office of Public Health (FOPH) Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2
2019     Swiss Federal Office of Public Health (FOPH) Assessment of knee arthroscopy for the treatment of degenerative changes
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Olaparib (Lynparza®) as first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Atezolizumab (Tecentriq®) with nab-paclitaxel (Abraxane®) for the treatment of advanced triple-negative breast cancer (aTNBC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections. EUnetHTA-Report
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Evaluation methods for the benefit assessment of easily accessible, outpatient health centres for vulnerable groups - Target group focus: Homeless and non-insured persons
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Robot-assisted surgery in thoracic and visceral indications
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Darolutamide for the treatment of patients with nonmetastatic castration-resistant prostate cancer (CRPC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Annulus Fibrosus Repair after lumbar discectomy
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Single/two-step scaffold-based cartilage repair in the knee and ankle joint
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Radiofrequency denervation for lumbar and cervical facet joint pain – a systematic review
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea. 1st Update 2019
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osteochondral allograft transplantation for the knee (or other joints)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Allograft for anterior and posterior cruciate ligament reconstruction
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Human dermal allograft for massive rotator cuff tears
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) 177Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Custom-made or customisable 3D printed implants and cutting guides versus non- 3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Brentuximab vedotin (Adcetris®) in combination with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCLs)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Irreversible electroporation for the treatment of liver and pancreatic cancer
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening and prevention programmes for children and adolescents from 6 to 14 years. Results from selected countries and recommendations from evidence-based guidelines
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening for Diabetes mellitus: guideline recommendations
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) FoundationOne®CDx: genetic profiling of solid tumours
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide (Xtandi®) in addition to standard first-line therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Sponsoring of Patient Initiatives in Austria 2018. Update of the Systematic Analyses 2014, 2015 and 2016
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pharma: Disclosure of transfers of value in Austria 2018. Update of the systematic analysis 2015
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening programs for children and adolescents from 6 to 18 years. Results on selected countries, Austrian screening programmes and recommendations from evidence-based guidelines
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rehabilitation for children and adolescents in Austria: A systematic analysis of evaluation methodologies
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cervical Carcinoma Prevention - Implementation of an HPV screening test for early detection of cervical cancer in Austria
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) POCT/ Point of Care Tests: D-Dimer and Troponin
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Minimum volume standards for quality assurance in day surgery: Fundamentals and Systematic Review
2019     Center for Drug Evaluation (CDE) Assessment of the benefits of community day-care facilities for the physically and mentally handicapped
2019     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Treatment of benign thyroid nodules by thermal laser or radiofrequency ablation]
2019     Health Quality Ontario (HQO) Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Cervical Artificial Disc Replacement Versus Fusion for Cervical Degenerative Disc Disease: A Health Technology Assessment
2019     Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder: an update
2019     Technology Assessment at SickKids (TASK) The economic evaluation of early intervention with anti-tumor necrosis factor-α treatments in pediatric Crohn's disease
2019     Technology Assessment at SickKids (TASK) A cost-utility analysis of biosimilar infliximab compared to reference infliximab in adult switch patients with Crohn’s disease: a Canadian analysis
2019     Health Quality Ontario (HQO) Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis
2019     Health Quality Ontario (HQO) Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2019     Ontario Health Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment
2019     Health Sciences Institute in Aragon (IACS) Efficacy, effectiveness and safety of intraoperative radiotherapy in breast carcinoma
2019     Health Sciences Institute in Aragon (IACS) Detection of diabetes' complications. Diabetic retinopathy. Economic evaluation of ultra-wide field scanning laser
2019     Ontario Health Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment
2019     Ontario Health Minimally Invasive Glaucoma Surgery: A Budget Impact Analysis and Evaluation of Patients’ Experiences, Preferences, and Values
2019     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Enzalutamide (prostate cancer) - Addendum to Commission A18-80]
2019     Basque Office for Health Technology Assessment (OSTEBA) Closed vs open systems for the preparation and administration of cytostatic and other hazardous drugs (NIOSH Group 1): analysis of the scientific evidence, costs and organisational requirements
2019     Belgian Health Care Knowledge Centre (KCE) Bariatric surgery : an HTA report on the efficacy, safety and cost-effectiveness